Cancer in a drop: Advances in liquid biopsy in 2024Roberto Borea, Carolina Reduzzi, Angelo Dipasquale et al.|Critical Reviews in Oncology/Hematology|2025Cited by 31
Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patientsFederica Miglietta, Grazia Arpino, Letizia Pontolillo et al.|The Breast|2024Cited by 9
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapyLuca Mastrantoni, Emilio Bria, Giovanna Garufi et al.|npj Breast Cancer|2025Cited by 9
Accessible Machine Learning and Deep Learning Models Predict Response and Survival in Early Stage Hormone Receptor-Positive/HER2-Negative Breast Cancer Receiving Neoadjuvant ChemotherapyGiovanna Garufi, Emilio Bria, Luca Mastrantoni et al.|Research Square|2024Cited by 0